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Classical swine fever (CSF) is a highly contagious swine infectious disease and
causes significant economic losses for the pig industry worldwide. The objective of
this study was to determine whether small molecule metabolites contribute to the
pathogenesis of CSF. Birefly, serum metabolomics of CSFV Shimen strain-infected
piglets were analyzed by ultraperformance liquid chromatography/electrospray ionization
time-of-flight mass spectrometry (UPLC/ESI-Q-TOF/MS) in combination with multivariate
statistical analysis. In CSFV-infected piglets at days 3 and 7 post-infection changes
were found in metabolites associated with several key metabolic pathways, including
tryptophan catabolism and the kynurenine pathway, phenylalanine metabolism, fatty
acid and lipid metabolism, the tricarboxylic acid and urea cycles, branched-chain amino
acid metabolism, and nucleotide metabolism. Several pathways involved in energy
metabolism including fatty acid biosynthesis and β-oxidation, branched-chain amino acid
metabolism, and the tricarboxylic acid cycle were significantly inhibited. Changes were
also observed in several metabolites exclusively associated with gut microbiota. The
metabolomic profiles indicate that CSFV-host gut microbiome interactions play a role
in the development of CSF.
Keywords: metabolomic profiling, UPLC-MS, CSFV, metabolite
INTRODUCTION
Classical swine fever (CSF) is a highly contagious swine infectious disease with high morbidity
and mortality caused by CSFV, featuring high fever, severe depression, extensive hemorrhage,
leucopenia, anorexia, and alternating constipation and diarrhea (Moennig et al., 2003). A notifiable
disease of the OIE-World Organization for Animal Health, CSF causes major economic losses in
many countries worldwide. CSFV replicates in organs with leucocytes, particularly mononuclear
macrophages, as its target cells, causing malfunction or failure of multiple body components,
including the immune, circulative, digestive, locomotor, reproductive, and respiratory systems
(Floegel-Niesmann et al., 2003). While a detailed analysis of CSFV infection has identified various
factors involved in viral replication and virulence (Ji et al., 2015), a comprehensive analysis of the
host response to CSFV infection is necessary to decipher the underlying molecular mechanism
of viral pathogenesis. Systems biology with high throughput techniques provides a powerful tool
to reveal global changes in gene expression and metabolism associated with disease progression.
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Alterations in genomic expression profiles and the host proteome
after CSFV infection have been determined using transcriptomics
and proteomics in studies focused on elucidating alterations in
upstream transcripts and proteins in virus-infected leukocytes,
mononucleocytes, and PK-16 cells (Sun et al., 2008, 2010;
Shi et al., 2009). However, global changes of small molecule
metabolites in CSFV-infected piglets have not yet been reported.
Metabolomics is a powerful tool for capturing the global
profiling of small molecule metabolites in a biological system
and has been extensively used to assess the physiological and
pathological status of human and animals (Lu et al., 2012; Guo
et al., 2015). Mounting evidence indicates that the metabolome
obtained under specific conditions displays unique chemical
characterizations, thereby showing great promise for biomarker
identification and diagnosis of diseases such as cancers and
neurodegenerative and viral diseases (Cui et al., 2013; Sun et al.,
2013; Ni et al., 2014). Indeed, small molecule metabolites are
the end products of cellular processes and can directly influence
the phenotype to a greater extent than transcripts and proteins
(Zhou et al., 2012; Cui et al., 2013; Sun et al., 2013). So far, LC-
MS or GC-MS-based metabolomics have been used to capture
global changes in small molecule metabolites in the body fluids
of patients infected with HIV, HCV, HBV, and dengue virus with
some of the significantly altered metabolites serving as potential
biomarkers of these viral diseases (Sun et al., 2013; Cui et al.,
2013; Zhou et al., 2012). By identifying perturbed biochemical
networks and metabolic pathways, metabolomic studies might
also provide targets for future disease therapy.
In the present study, serum samples from highly virulent
CSFV-infected piglets and healthy control were subjected
to metabolomics analysis using ultraperformance liquid-
chromatography/electrospray ionization-time of flight-mass
spectrometry (UPLC/ESI-Q-TOF/MS). We show that the serum
metabolome obtained through multivariate statistical analysis
can separate CSFV-infected piglets from healthy control animals,
and that the altered metabolic pathways may be associated with
disease development and progression of CSF.
EXPERIMENTAL SECTION
Animal Experiments
Weaning piglets of (30 days old; n = 20), free of porcine
reproductive and respiratory syndrome virus (PRRSV), bovine
viral diarrhea virus (BVDV), porcine circovirus type 2 (PCV-
2), pseudorabies virus (PRV), and porcine parvovirus (PPV),
were purchased from Jiangshu Yongkang Husbandry Company
(Jiangshu, China). The piglets were randomly divided into two
groups of 10 (infected and control) and housed in a room
of negative-pressure facilities in Sinovet Company (Jiangshu,
China), five piglets per pen. The animals were allowed free access
to standard diet and water. The animal studies were approved by
the Experimental Animal Use and Care Committee, Academy of
Military Medical Sciences, China.
After a 7-day observation period piglets in the infected group
were intramuscularly injected with 106 TCID50 of the highly
virulent Shimen strain of CSFV with controls receiving an equal
volume of PBS. Rectal temperatures were recorded each morning
and animals were observed daily for clinical signs. Leukocyte
counts were measured on whole blood samples collected from
piglets at 0, 3, and 7 days post-infection (dpi) using aMedonic CA
620 counter (Boule Medical AB, Stockholm, Sweden). Viremia of
whole blood collected from CSFV-infected piglets at dpi 3 and
7 were measured by real-time PCR as described previously (Shi
et al., 2009).
Serum Collection
Blood was collected via the precaval vein into BD Vacutainer
Rapid Serum Tubes (BD, Franklin Lakes, New Jersey, USA) and
serum was harvested by centrifugation at 2,000 g for 10 min at
4◦C. Samples were stored at−80◦C until use.
UPLC/ESI-Q-TOF/MS Analysis of Serum
Extracts
For UPLC/ESI–Q-TOF/MS analysis, a 200 µl aliquot of serum
was mixed with 600 µl methanol, vortexed for 1 min, and
centrifuged at 12,000 g for 15 min at 4◦C. A 5 µl aliquot of the
resulting supernatant was injected into a 100× 2.1 mm2, 1.8 µm
HSS T3 column (Waters, Milford, MA) held at 40◦C using an
Agilent 1290 Infinity UPLC system (Santa Clara, CA). The binary
gradient elution system consisted of (A) water (containing 0.1%
formic acid, v/v) and (B) acetonitrile (containing 0.1% formic
acid, v/v) and separation was achieved using a linear gradient
which was run from 5% to 95% B over 30 min at 0.35 ml/min.
All samples were kept at 4◦C during the analysis. The mass
spectrometric data was collected using an Agilent 6538 UHD and
Accurate-Mass Q-TOF/MS system equipped with an electrospray
ionization (ESI) source operating in either positive or negative
ion mode. Two reference masses were continuously infused to
the system to allow constant mass correction during the run, with
reference masses in the positive and negative ion modes of m/z
121.0509 and 922.0098, and m/z 112.985587 and 1033.988109
respectively. The ESI source parameters were: capillary voltage
of 4.0 kV for positive mode and 3.5 kV for negative mode, gas
temperature of 350◦C, gas flow of 11 L/min, nebulizer of 45 psi,
fragmentor of 120 V, skimmer of 60 V, and octopole RF Peak of
750 V.
Data Processing and Analysis
The raw ULPC-MS ESI data were converted to mzXML using
MassHunter Workstation software from Agilent (Santa Clara,
CA, USA), and the file was then imported into XCMS software
in the R platform (Scripps, La Jolla, CA, USA) for preprocessing,
including peak picking, alignment, integration and retention
time (RT) alignment. An Excel file was obtained with three
dimension data sets including m/z, peak RT, and normalized
peak intensities, and RT–m/z pairs were used as the identifier
for each ion. The multivariate data matrix was analyzed with
Simca-P 11.0 (Umetrics, Umea, Sweden). To reveal metabolic
changes occurring following infection, the unsupervised method
(primary component analysis, PCA) was utilized to provide
an overview of systemic variations and general clustering
among all groups, and the supervised method (partial least-
square discriminant analysis, PLS-DA) was utilized to identify
differential metabolites accounting for the separation between
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groups of piglets. Potential differential metabolites were selected
according to the Variable Importance in the Projection (VIP)
values and the variables with VIP>1 were considered to be
influential for the separation of samples in PLS-DA analysis.
In addition, the Student’s t-test was applied to determine if the
differential metabolites obtained from PLS-DA modeling were
statistically significant (p < 0.05) among groups at the univariate
analysis level.
Identification of differential metabolites was performed as
following: first, the element composition of the specific m/z
ion was calculated based on the exact mass, the nitrogen
rule and the isotype pattern by Masshunter software from
Agilent. Then, the elemental composition and exact mass were
used for open source database searching, including METLIN
(http://metlin.scripps.edu/). In addition, Kyoto Encyclopedia of
Genes and Genomes (http://www.genome.jp/kegg/) was used to
identify the alteredmetabolic pathways in piglets following CSFV
infection.
RESULTS
Clinical Presentations of Piglets Infected
with CSFV
After infection with CSFV virulent Shimen strain, viremia was
detected at low level (105.0 genome copies/ml) in piglets at dpi 3
and reached high level at about 109.0 genome copies/ml at dpi 7
(Figure 1A). Typical CSF characteristics including high fever and
leukopenia were observed in CSFV-infected piglets. As shown
in Figure 1B, the rectal temperature of infected piglets (SM)
increased from 39.6◦C at dpi 0 to≥40.3◦C at dpi 1, peaking at dpi
3 (40.9◦C), while no significant changes in rectal temperatures
were observed in the controls. In addition, leukocyte counts in
infected piglets dropped by ∼50% by dpi 3 and dpi 7 while
control levels remained unchanged (Figure 1C). Alternating
constipation and diarrhea, convulsions, depression, and coma
were also observed in CSFV-infected piglets. Of note is that one
of the infected piglets did not show any clinical signs until dpi
8, while serum samples collected at dpi 3 and 7 from this animal
were included in the metabolomic analysis.
Metabolomic Analysis of Serum
Metabolites
Serum metabolomic profiles following CSFV infection were
characterized using UPLC/ESI-Q-TOF/MS, and PCA and PLS-
DA were applied to the data. QC data showing no drift of
stable retention time in all peaks indicated that the quality of
data was acceptable for the following metabolomic analysis. PCA
score plots revealed clear separation between the uninfected
and infected piglets under both positive and negative modes
(Figures 2A,B). Further, distinct metabolic profiles in infected
animals were observed before (dpi 0) and after infection (dpi 3
and 7), but no significant separation was observed in the control.
The UPLC-MS data were further processed by a PLS-
DA scores plot. The quality of the PLS-DA model was
evaluated by R2Y and Q2 parameters, which indicated the
fitness and prediction ability, respectively. PLS-DA score plots
revealed excellent separation of the uninfected and infected
piglets (Figures 2C,D). The first 2-component PLS-DA scores
plot of serum metabolites showed that infected piglets were
clearly distinguished from uninfected ones by the principal
component t[1].
Effect of Infection Duration on Metabolite
Profile in CSFV-Infected Piglets
Differential metabolites obtained through UPLC/ESI-Q-
TOF/MS were selected based on the criteria VIP > 1 in
OPLS-DA analysis and P < 0.05 in the Student’s t-test (Table 1).
The changed metabolites were associated with several key
metabolic pathways, including tryptophan catabolism and the
kynurenine pathway, phenylalanine metabolism, fatty acid and
lipid metabolism, the citric acid and urea cycles, and branched-
chain amino acid, and nucleotide metabolism. Different stages
of CSFV infection had a significant impact on the metabolite
profiles, as reflected in both the number and fold changes of
altered serummetabolites detected at dpi 3 and 7 (Table 1). These
differential metabolites show three different time-course trends:
elevated-elevated, elevated-decreased, and decreased-decreased,
as depicted in the hierarchical clustering heat map (Figure 3).
Specifically, a total of six saturated and unsaturated long
chain fatty acids, 2 acylcarnitines, 3 branched-chain amino
acids (BCAAs) and their derivatives (L-α-hydroxyisovaleric
acid, α-ketoisovaleric acid, and 3-methyl-2-oxovaleric acid),
phenylalanine and its derivatives (trans-cinnamic acid,
dopamine, and 4-aminosalicylic acid), tryptophan derivatives
(kynurenine, quinolinic acid, and isonicotinic acid), urea,
uric acid, allantoin, p-cresol sulfate, creatine, creatinine, and
bilirubin showed an elevated trend at both dpi 3 and 7 (Figure 4
and Table 1). Three steroids (cortisol, 25-hydroxyvitamin D3,
cholesterol sulfate) also showed an upward trend during CSFV
infection (Figure 4 and Table 1). Conversely, phospholipids,
5 intermediates in the TCA cycle and 2 intermediates in the
urea cycle, 2 nucleosides (cytidine and guanine), 3 quinolinic
acid derivatives (trigonelline, niacinamide, and 3-furoic acid),
amino acids (threonine, tyrosine, and methionine), and 2,3-
dihydroxybenzoic acid displayed a downward trend (Figure 4
and Table 1). Guanosine, cytosine, glycocholic acid, deoxycholic
acid, acetylcholine, equol, N1-acetylspermidine, caffeine, glycine,
phenylacetylglycine, sphingosine-1-phosphate, and α-D-glucose
showed an increasing trend at dpi 3 but normalized to control
levels by dpi 7 (Figure 4 and Table 1).
Altered Energy and Lipid Metabolism in
CSFV-Infected Piglets
The TCA cycle is important in energy production for the
biochemical processes in the body. Intermediates, including
citric, succinic, fumaric, and malic acids, decreased as the
infection developed except for an up-regulation of oxaloacetate
in the late stages (Figure 4), indicating the blocking of
energy production in CSFV infected piglets. Substantial levels
of saturated fatty acids (palmitic, 2-hydroxyhexahecanoic
and stearic acids), and unsaturated fatty acids (oleic, LTB5,
and linoleic acids), as well as acyl carnitines, including
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FIGURE 1 | Pigs infected with CSFV Shimen strain developed viremia, high fever, and leucopenia. Pigs were infected with CSFV Shimen strain (SM) and
healthy control pigs were treated with PBS. Viremia was detected only in Shimen-infected piglets at dpi 3 and dpi 7 (A). High fever (>40.5◦C, B) and leucopenia (C)
occurred in piglets infected with CSFV only.
palmitoyl-L-carnitine, acetylcarnitine and butyryl-L-carnitine
accumulated in the serum of infected piglets (Figure 4 and
Table 1).
Accumulation of these compounds may indicate that
energy production through fatty acid β-oxidation was
perturbed. Another energy production pathway, degradation of
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FIGURE 2 | Score plots of principal component analysis (PCA) and partial least-square discriminant analysis (PLS-DA) of serum extracts from healthy
controls and piglets infected with CSFV. The principal component analysis (PCA) (A, negative ion mode-ESI-; B, positive ion mode-ESI+) and partial least-square
discriminant analysis (PLS-DA) (C, negative ion mode-ESI-; D, positive ion mode-ESI+) models were constructed using UPLC-MS metabolomics data from healthy
subjects and CSFV-infected piglets (SM) at three different time points. Results indicate the separation of healthy subjects and infected piglets. The ellipses represent
95% confidence intervals of all samples.
branched-chain amino acids (BCAA) to acetyl-CoA and succinyl
CoA, may also be inhibited because of the accumulation of
BCAAs (valine, leucine, and isoleucine) and their derivatives
after CSFV infection. Other amino acids associated with energy
production, such as methionine and threonine, showed a
downward trend in infected piglets (Figure 4 and Table 1).
Furthermore, a short chain fatty acid, propionic acid, which
is also used for energy production by gut bacteria, was down-
regulated during infection (Table 1). In addition, pantothenic
acid used for the synthesis of coenzyme A was found to be first
increased at dpi 3, then decreased at dpi 7 (Table 1). Taken
together, energy metabolism was significantly inhibited in piglets
infected with the highly virulent CSFV strain.
Altered Aromatic Amino Acid Metabolism
in CSFV–Infected Piglets
Indole-containing compounds 3-indolepropionic acid (IPA) and
indoleacetaldehyde were down-regulated at dpi 7 in infected
piglets, but another indole derivative, indoxylsulfuric acid, was
elevated (Table 1). Production of these indole derivatives is
associated with gut microbiotic metabolism. In particular, IPA is
a metabolite produced by certain types of intestinal bacteria, and
its decrease may reflect perturbation of gut microflora by CSFV
infection.
The metabolism of another indole-containing compound
tryptophan was also significantly altered in CSFV-infected
piglets. Tryptophan is an essential amino acid for animals
and can be metabolized through several pathways. One key
route, the tryptophan-kynurenine pathway, was activated
following CSFV infection, as reflected in the increased
serum levels of kynurenine and its derivative quinolinic
acid, concomitantly with down-regulation of quinolinic
acid derivatives (trigonelline and niacinamide) (Figure 4
and Table 1). Likewise, a metabolite in another tryptophan
metabolism pathway, serotonin, was significantly decreased
during infection (Table 1).
Phenylalanine metabolism was also changed by infection.
Phenylalanine derivatives, including phenylacetylglycine
Frontiers in Microbiology | www.frontiersin.org 5 April 2017 | Volume 8 | Article 731
Gong et al. Serum Metabolomics of CSFV-Infected Piglets
T
A
B
L
E
1
|
D
if
fe
re
n
ti
a
l
m
e
ta
b
o
li
te
s
in
C
S
F
V
-i
n
fe
c
te
d
p
ig
le
ts
c
o
m
p
a
re
d
to
h
e
a
lt
h
y
c
o
n
tr
o
ls
.
M
e
ta
b
o
li
te
s
P
a
th
w
a
y
V
IP
[1
]
t-
te
s
t
F
C
(S
M
-d
p
i
3
v
s
.
S
M
-d
p
i
0
)
V
IP
[1
]
t-
te
s
t
F
C
(S
M
-d
p
i
7
v
s
.
S
M
-d
p
i
0
)
M
o
d
e
B
ili
ru
b
in
H
e
m
e
c
a
ta
b
o
lis
m
1
.2
6
1
.7
0
E
-0
5
1
7
.2
4
1
.1
0
1
.9
0
E
-0
3
6
.2
2
E
S
I+
L
-O
rn
ith
in
e
A
rg
in
in
e
a
n
d
p
ro
lin
e
m
e
ta
b
o
lis
m
1
.2
6
1
.5
3
E
-0
4
−
1
.9
6
E
S
I+
C
itr
u
lli
n
e
A
rg
in
in
e
a
n
d
p
ro
lin
e
m
e
ta
b
o
lis
m
1
.3
8
1
.7
6
E
-0
5
−
1
.7
8
E
S
I−
C
re
a
tin
e
A
rg
in
in
e
a
n
d
p
ro
lin
e
m
e
ta
b
o
lis
m
0
.9
5
4
.1
6
E
-0
3
3
.2
1
1
.3
7
9
.7
3
E
-0
6
5
.0
6
E
S
I+
C
re
a
tin
in
e
A
rg
in
in
e
a
n
d
p
ro
lin
e
m
e
ta
b
o
lis
m
1
.1
0
5
.2
3
E
-0
4
1
.9
9
0
.9
2
1
.4
1
E
-0
2
1
.2
9
E
S
I+
U
re
a
A
rg
in
in
e
a
n
d
p
ro
lin
e
m
e
ta
b
o
lis
m
1
.2
7
1
.0
5
E
-0
5
8
.9
6
1
.3
4
2
.3
2
E
-0
5
1
0
.7
0
E
S
I+
L
-P
ro
lin
e
A
rg
in
in
e
a
n
d
p
ro
lin
e
m
e
ta
b
o
lis
m
1
.1
4
2
.5
9
E
-0
4
−
1
.6
8
1
.3
4
2
.4
9
E
-0
5
−
2
.3
5
E
S
I+
U
ric
a
c
id
P
u
rin
e
m
e
ta
b
o
lis
m
1
.1
6
5
.5
9
E
-0
4
2
.5
1
1
.3
6
2
.6
4
E
-0
5
4
.2
2
E
S
I−
A
lla
n
to
in
P
u
rin
e
m
e
ta
b
o
lis
m
1
.4
2
9
.9
7
E
-0
7
3
.8
4
1
.3
2
7
.4
0
E
-0
5
3
.9
4
E
S
I−
p
-C
re
so
ls
u
lfa
te
A
ro
m
a
tic
c
o
m
p
o
u
n
d
s
1
.0
9
1
.5
4
E
-0
3
3
.1
5
0
.9
5
1
.2
5
E
-0
2
3
.3
7
E
S
I−
L
-P
h
e
n
yl
a
la
n
in
e
P
h
e
n
yl
a
la
n
in
e
m
e
ta
b
o
lis
m
1
.2
7
1
.1
6
E
-0
5
2
.8
1
1
.3
4
2
.5
5
E
-0
5
1
.8
0
E
S
I+
P
h
e
n
yl
a
c
e
ty
lg
ly
c
in
e
P
h
e
n
yl
a
la
n
in
e
m
e
ta
b
o
lis
m
0
.7
8
3
.5
3
E
-0
2
1
.6
7
0
.9
5
1
.3
1
E
-0
2
−
1
.4
5
E
S
I−
B
e
n
zo
ic
a
c
id
P
h
e
n
yl
a
la
n
in
e
m
e
ta
b
o
lis
m
0
.8
4
1
.4
1
E
-0
2
−
1
.4
8
1
.0
2
5
.0
1
E
-0
3
−
1
.5
2
E
S
I+
G
ly
c
in
e
G
ly
c
in
e
,
se
rin
e
a
n
d
th
re
o
n
in
e
m
e
ta
b
o
lis
m
0
.7
5
4
.3
1
E
-0
2
1
.6
4
0
.9
8
9
.3
9
E
-0
3
−
1
.5
0
E
S
I−
D
L
-2
-A
m
in
o
o
c
ta
n
o
ic
a
c
id
A
m
in
o
c
o
m
p
o
u
n
d
1
.2
2
3
.4
3
E
-0
4
−
4
.4
8
E
S
I+
4
-H
yd
ro
xy
b
e
n
ze
n
e
su
lfo
n
ic
a
c
id
A
ro
m
a
tic
a
m
in
o
a
c
id
0
.8
6
2
.6
4
E
-0
2
1
5
.1
5
E
S
I−
H
ip
p
u
ric
a
c
id
P
h
e
n
yl
a
la
n
in
e
m
e
ta
b
o
lis
m
0
.8
8
2
.0
4
E
-0
2
−
2
.0
0
E
S
I+
L
-T
yr
o
si
n
e
P
h
e
n
yl
a
la
n
in
e
m
e
ta
b
o
lis
m
0
.8
4
1
.4
0
E
-0
2
−
1
.6
3
1
.0
2
5
.3
5
E
-0
3
−
1
.6
6
E
S
I−
D
o
p
a
m
in
e
P
h
e
n
yl
a
la
n
in
e
m
e
ta
b
o
lis
m
1
.1
0
4
.7
1
E
-0
4
1
.3
4
1
.2
9
8
.5
9
E
-0
5
1
.5
5
E
S
I+
tr
a
n
s-
C
in
n
a
m
ic
a
c
id
P
h
e
n
yl
a
la
n
in
e
m
e
ta
b
o
lis
m
1
.2
7
1
.2
3
E
-0
5
2
.8
5
1
.3
4
2
.2
4
E
-0
5
1
.7
5
E
S
I+
4
-A
m
in
o
sa
lic
yl
ic
a
c
id
P
h
e
n
yl
a
la
n
in
e
m
e
ta
b
o
lis
m
0
.8
3
1
.5
1
E
-0
2
2
.3
6
1
.3
1
5
.0
2
E
-0
5
5
.3
6
E
S
I+
2
,3
-D
ih
yd
ro
xy
b
e
n
zo
ic
a
c
id
B
e
n
zo
ic
a
c
id
m
e
ta
b
o
lis
m
1
.1
8
3
.7
8
E
-0
3
−
2
.8
7
1
.5
0
2
.2
6
E
-0
7
−
9
.4
0
E
S
I−
D
-R
ib
o
se
P
e
n
to
se
p
h
o
sp
h
a
te
p
a
th
w
a
y
0
.8
9
8
.7
3
E
-0
3
−
1
.6
3
1
.0
0
6
.7
8
E
-0
3
−
1
.5
3
E
S
I+
G
lu
c
o
n
ic
a
c
id
P
e
n
to
se
p
h
o
sp
h
a
te
p
a
th
w
a
y
1
.1
3
1
.8
1
E
-0
3
−
1
.5
2
E
S
I−
α
-D
-G
lu
c
o
se
G
ly
c
o
ly
si
s/
G
lu
c
o
n
e
o
g
e
n
e
si
s
0
.7
6
2
.9
0
E
-0
2
1
.3
1
0
.9
5
1
.1
1
E
-0
2
−
2
.1
4
E
S
I+
L
-L
a
c
tic
a
c
id
G
ly
c
o
ly
si
s/
G
lu
c
o
n
e
o
g
e
n
e
si
s
1
.2
5
2
.9
8
E
-0
4
−
2
.2
5
E
S
I−
D
-S
o
rb
ito
l
G
lu
c
o
se
m
e
ta
b
o
lis
m
1
.0
4
2
.7
7
E
-0
3
−
1
.6
0
1
.2
3
4
.0
3
E
-0
4
−
1
.7
7
E
S
I−
It
a
c
o
n
ic
a
c
id
T
C
A
c
yc
le
1
.4
2
9
.9
2
E
-0
7
−
2
.0
7
1
.4
8
5
.8
1
E
-0
7
−
3
.1
9
E
S
I−
C
itr
ic
a
c
id
T
C
A
c
yc
le
1
.4
4
4
.7
7
E
-0
7
−
2
.1
6
1
.5
4
2
.7
9
E
-0
8
−
4
.0
6
E
S
I−
tr
a
n
s-
A
c
o
n
ita
te
T
C
A
c
yc
le
1
.4
5
4
.0
3
E
-0
7
−
1
.9
3
1
.4
7
9
.3
8
E
-0
7
−
3
.0
6
E
S
I−
S
u
c
c
in
ic
a
c
id
T
C
A
c
yc
le
1
.1
9
3
.5
7
E
-0
4
−
1
.9
9
1
.3
4
4
.6
2
E
-0
5
−
3
.3
6
E
S
I−
L
-M
a
lic
a
c
id
T
C
A
c
yc
le
1
.3
3
1
.7
0
E
-0
5
−
2
.4
0
1
.3
8
1
.6
5
E
-0
5
−
3
.0
1
E
S
I−
F
u
m
a
ric
a
c
id
T
C
A
c
yc
le
1
.3
2
2
.1
6
E
-0
5
−
2
.2
6
1
.4
2
5
.5
3
E
-0
6
−
3
.5
3
E
S
I−
O
xa
lo
a
c
e
ta
te
T
C
A
c
yc
le
1
.0
2
4
.9
5
E
-0
3
2
.3
5
E
S
I+
P
a
n
to
th
e
n
ic
A
c
id
B
e
ta
-A
la
n
in
e
m
e
ta
b
o
lis
m
0
.8
9
1
.4
7
E
-0
2
−
1
.2
8
1
.4
0
1
.0
9
E
-0
5
−
2
.9
1
E
S
I−
L
-A
sc
o
rb
ic
a
c
id
G
lu
ta
th
io
n
e
m
e
ta
b
o
lis
m
1
.1
4
1
.5
8
E
-0
3
−
6
.7
2
E
S
I−
A
d
e
n
o
si
n
e
m
o
n
o
p
h
o
sp
h
a
te
P
u
rin
e
m
e
ta
b
o
lis
m
1
.4
4
5
.8
5
E
-0
9
−
3
.7
1
1
.3
1
4
.6
4
E
-0
5
−
2
.3
9
E
S
I+
1
-M
e
th
yl
a
d
e
n
o
si
n
e
M
e
th
yl
a
tio
n
1
.4
0
3
.9
8
E
-0
6
−
1
.8
0
E
S
I+
C
yt
id
in
e
P
yr
im
id
in
e
m
e
ta
b
o
lis
m
1
.0
6
1
.0
0
E
-0
3
−
1
.5
3
1
.4
0
4
.0
4
E
-0
6
−
1
.9
9
E
S
I+
C
yt
o
si
n
e
P
yr
im
id
in
e
m
e
ta
b
o
lis
m
1
.1
6
1
.5
2
E
-0
4
2
.1
2
1
.2
0
4
.1
8
E
-0
4
−
1
.5
7
E
S
I+
(C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 6 April 2017 | Volume 8 | Article 731
Gong et al. Serum Metabolomics of CSFV-Infected Piglets
T
A
B
L
E
1
|
C
o
n
ti
n
u
e
d
M
e
ta
b
o
li
te
s
P
a
th
w
a
y
V
IP
[1
]
t-
te
s
t
F
C
(S
M
-d
p
i
3
v
s
.
S
M
-d
p
i
0
)
V
IP
[1
]
t-
te
s
t
F
C
(S
M
-d
p
i
7
v
s
.
S
M
-d
p
i
0
)
M
o
d
e
3
-M
e
th
yl
c
yt
o
si
n
e
P
yr
im
id
in
e
m
e
ta
b
o
lis
m
1
.2
2
2
.9
7
E
-0
4
−
1
.6
5
E
S
I+
D
e
o
xy
u
rid
in
e
m
o
n
o
p
h
o
sp
h
a
te
(d
U
M
P
)
P
yr
im
id
in
e
m
e
ta
b
o
lis
m
0
.8
5
1
.2
9
E
-0
2
1
.6
2
1
.1
5
1
.0
3
E
-0
3
−
1
.9
1
E
S
I+
G
u
a
n
in
e
P
u
rin
e
m
e
ta
b
o
lis
m
1
.0
4
1
.2
6
E
-0
3
−
1
.2
8
1
.3
0
5
.8
1
E
-0
5
−
1
.7
1
E
S
I+
G
u
a
n
o
si
n
e
P
u
rin
e
m
e
ta
b
o
lis
m
0
.9
5
4
.4
5
E
-0
3
5
.3
3
1
.0
4
4
.0
0
E
-0
3
−
2
.9
3
E
S
I+
In
o
si
n
e
P
u
rin
e
m
e
ta
b
o
lis
m
0
.8
4
1
.4
4
E
-0
2
4
.7
5
E
S
I+
C
a
ff
e
in
e
C
a
ff
e
in
e
m
e
ta
b
o
lis
m
0
.7
6
2
.9
7
E
-0
2
2
.1
2
0
.8
9
1
.8
1
E
-0
2
−
1
.3
7
E
S
I+
K
yn
u
re
n
in
e
Tr
yp
to
p
h
a
n
m
e
ta
b
o
lis
m
0
.8
6
1
.1
1
E
-0
2
1
0
.1
3
1
.0
8
2
.6
1
E
-0
3
1
2
.6
3
E
S
I+
Q
u
in
o
lin
ic
a
c
id
Tr
yp
to
p
h
a
n
m
e
ta
b
o
lis
m
1
.1
0
1
.4
1
E
-0
3
2
.5
3
1
.2
4
3
.5
0
E
-0
4
6
.0
8
E
S
I−
S
e
ro
to
n
in
Tr
yp
to
p
h
a
n
m
e
ta
b
o
lis
m
1
.3
8
7
.2
3
E
-0
6
−
6
.9
0
E
S
I+
Is
o
n
ic
o
tin
ic
a
c
id
Tr
yp
to
p
h
a
n
m
e
ta
b
o
lis
m
1
.0
7
2
.0
7
E
-0
3
2
.3
8
1
.2
2
5
.0
6
E
-0
4
5
.4
3
E
S
I−
3
-F
u
ro
ic
a
c
id
Tr
yp
to
p
h
a
n
m
e
ta
b
o
lis
m
1
.4
2
9
.7
9
E
-0
7
−
2
.2
6
1
.4
5
2
.0
4
E
-0
6
−
2
.9
7
E
S
I−
Tr
ig
o
n
e
lli
n
e
Tr
yp
to
p
h
a
n
m
e
ta
b
o
lis
m
1
.0
4
1
.3
0
E
-0
3
−
1
.5
4
1
.4
0
4
.2
9
E
-0
6
−
3
.6
6
E
S
I+
N
ia
c
in
a
m
id
e
Tr
yp
to
p
h
a
n
m
e
ta
b
o
lis
m
1
.1
6
1
.4
9
E
-0
4
−
1
.9
3
1
.1
3
1
.2
6
E
-0
3
−
2
.1
5
E
S
I+
In
d
o
le
a
c
e
ta
ld
e
h
yd
e
Tr
yp
to
p
h
a
n
m
e
ta
b
o
lis
m
1
.3
8
6
.7
6
E
-0
6
−
6
.7
4
E
S
I+
3
-I
n
d
o
le
p
ro
p
io
n
ic
a
c
id
Tr
yp
to
p
h
a
n
m
e
ta
b
o
lis
m
1
.2
2
3
.2
7
E
-0
4
−
5
.9
1
E
S
I+
In
d
o
xy
ls
u
lfu
ric
a
c
id
Tr
yp
to
p
h
a
n
m
e
ta
b
o
lis
m
1
.3
7
2
.4
8
E
-0
5
2
.9
1
E
S
I−
L
-I
so
le
u
c
in
e
B
ra
n
c
h
e
d
c
h
a
in
a
m
in
o
a
c
id
s
(B
C
A
A
)
0
.7
4
3
.3
1
E
-0
2
1
.2
3
1
.2
7
1
.1
8
E
-0
4
1
.6
9
E
S
I+
L
-L
e
u
c
in
e
B
ra
n
c
h
e
d
c
h
a
in
a
m
in
o
a
c
id
s
1
.1
5
2
.0
0
E
-0
4
1
.4
2
1
.4
1
3
.3
2
E
-0
6
1
.7
5
E
S
I+
L
-V
a
lin
e
B
ra
n
c
h
e
d
c
h
a
in
a
m
in
o
a
c
id
s
1
.3
9
1
.4
7
E
-0
7
2
.5
2
1
.4
3
1
.4
2
E
-0
6
3
.1
1
E
S
I+
3
-M
e
th
yl
-2
-o
xo
va
le
ric
a
c
id
B
C
A
A
m
e
ta
b
o
lis
m
1
.0
6
2
.3
9
E
-0
3
1
.3
7
1
.4
7
9
.3
3
E
-0
7
1
.9
7
E
S
I−
α
-k
e
to
is
o
va
le
ric
a
c
id
B
C
A
A
m
e
ta
b
o
lis
m
1
.4
0
2
.4
8
E
-0
6
3
.3
9
1
.4
7
1
.0
3
E
-0
6
4
.8
8
E
S
I−
L
-α
-H
yd
ro
xy
is
o
va
le
ric
a
c
id
B
C
A
A
m
e
ta
b
o
lis
m
1
.2
7
8
.1
6
E
-0
5
4
.1
5
1
.4
5
1
.5
3
E
-0
6
8
.4
1
E
S
I−
(±
)-
E
q
u
o
l
A
ro
m
a
tic
c
o
m
p
o
u
n
d
s
1
.2
2
1
.8
3
E
-0
4
2
.8
4
1
.3
1
9
.5
1
E
-0
5
−
3
.0
2
E
S
I−
A
c
e
ty
lc
a
rn
iti
n
e
C
a
rn
iti
n
e
0
.9
8
2
.8
5
E
-0
3
2
.2
8
0
.9
7
9
.0
2
E
-0
3
1
0
.7
5
E
S
I+
L
-C
a
rn
iti
n
e
C
a
rn
iti
n
e
1
.1
1
3
.9
0
E
-0
4
1
.5
0
1
.2
4
2
.2
3
E
-0
4
2
.3
8
E
S
I+
B
u
ty
ry
l-
L
-c
a
rn
iti
n
e
C
a
rn
iti
n
e
1
.3
0
6
.4
3
E
-0
5
5
.6
3
E
S
I+
P
a
lm
ito
yl
-L
-c
a
rn
iti
n
e
C
a
rn
iti
n
e
1
.3
1
2
.9
9
E
-0
6
7
.3
6
1
.3
3
3
.2
2
E
-0
5
1
0
.7
4
E
S
I+
P
ro
p
io
n
yl
-L
-c
a
rn
iti
n
e
C
a
rn
iti
n
e
1
.1
0
4
.9
6
E
-0
4
1
.8
0
E
S
I+
O
le
a
m
id
e
A
c
yl
a
m
id
e
1
.1
3
3
.0
0
E
-0
4
1
.5
9
1
.0
2
5
.4
5
E
-0
3
1
.1
9
E
S
I+
O
le
ic
A
c
id
U
n
sa
tu
ra
te
d
fa
tt
y
a
c
id
s
1
.0
7
7
.5
6
E
-0
4
6
.2
6
E
S
I+
L
in
o
le
ic
a
c
id
U
n
sa
tu
ra
te
d
fa
tt
y
a
c
id
s
1
.3
0
3
.5
9
E
-0
5
1
0
.7
8
1
.3
1
8
.3
9
E
-0
5
5
.9
1
E
S
I−
A
ra
c
h
id
o
n
ic
A
c
id
(p
e
ro
xi
d
e
fr
e
e
)
U
n
sa
tu
ra
te
d
fa
tt
y
a
c
id
s
1
.0
5
2
.5
1
E
-0
3
1
.5
8
E
S
I−
E
ic
o
sa
p
e
n
ta
e
n
o
ic
A
c
id
U
n
sa
tu
ra
te
d
fa
tt
y
a
c
id
s
1
.0
7
2
.8
5
E
-0
3
−
1
.5
5
E
S
I+
D
o
c
o
sa
h
e
xa
e
n
o
ic
A
c
id
e
th
yl
e
st
e
r
U
n
sa
tu
ra
te
d
fa
tt
y
a
c
id
s
0
.8
9
8
.4
5
E
-0
3
8
.6
3
E
S
I+
LT
B
5
U
n
sa
tu
ra
te
d
fa
tt
y
a
c
id
s
1
.1
5
1
.8
4
E
-0
4
1
0
.2
8
E
S
I+
P
a
lm
iti
c
a
c
id
F
a
tt
y
a
c
id
s
1
.2
0
2
.6
6
E
-0
4
1
7
.7
9
1
.2
7
2
.1
8
E
-0
4
8
.2
5
E
S
I−
S
te
a
ric
a
c
id
F
a
tt
y
a
c
id
s
1
.1
1
1
.1
6
E
-0
3
4
.7
4
1
.5
4
2
.5
9
E
-0
8
3
.9
5
E
S
I−
P
ro
p
io
n
ic
a
c
id
S
h
o
rt
c
h
a
in
fa
tt
y
a
c
id
s
1
.3
0
4
.2
4
E
-0
5
−
2
.4
8
1
.3
8
1
.6
7
E
-0
5
−
4
.0
0
E
S
I−
(C
o
n
ti
n
u
e
d
)
Frontiers in Microbiology | www.frontiersin.org 7 April 2017 | Volume 8 | Article 731
Gong et al. Serum Metabolomics of CSFV-Infected Piglets
T
A
B
L
E
1
|
C
o
n
ti
n
u
e
d
M
e
ta
b
o
li
te
s
P
a
th
w
a
y
V
IP
[1
]
t-
te
s
t
F
C
(S
M
-d
p
i
3
v
s
.
S
M
-d
p
i
0
)
V
IP
[1
]
t-
te
s
t
F
C
(S
M
-d
p
i
7
v
s
.
S
M
-d
p
i
0
)
M
o
d
e
2
-h
yd
ro
xy
h
e
xa
d
e
c
a
n
o
ic
a
c
id
H
yd
ro
xy
fa
tt
y
a
c
id
s
1
.4
0
2
.6
6
E
-0
6
3
.2
4
1
.4
5
1
.5
5
E
-0
6
1
.8
4
E
S
I−
2
-L
in
o
le
o
yl
G
ly
c
e
ro
l
A
c
yl
g
ly
c
e
ro
l
1
.1
9
8
.1
3
E
-0
5
1
.6
1
1
.2
2
3
.2
8
E
-0
4
1
.3
3
E
S
I+
A
ra
c
h
id
o
n
o
yl
d
o
p
a
m
in
e
T
R
P
V
1
lig
a
n
d
1
.1
4
1
.5
6
E
-0
3
3
.1
2
E
S
I−
Ta
u
rin
e
Ta
u
rin
e
1
.2
0
6
.2
7
E
-0
4
−
1
.6
4
E
S
I−
G
ly
c
e
ro
p
h
o
sp
h
o
-N
-A
ra
c
h
id
o
n
o
yl
E
th
a
n
o
la
m
in
e
A
c
yl
a
m
id
e
1
.0
8
6
.4
7
E
-0
4
2
.0
7
E
S
I+
L
-M
e
th
io
n
in
e
M
e
th
io
n
in
e
m
e
ta
b
o
lis
m
0
.9
5
4
.2
5
E
-0
3
−
1
.7
3
0
.9
8
8
.2
7
E
-0
3
−
1
.5
5
E
S
I+
N
1
-A
c
e
ty
ls
p
e
rm
id
in
e
M
e
th
io
n
in
e
m
e
ta
b
o
lis
m
1
.2
7
1
.0
1
E
-0
5
5
.4
6
0
.8
6
2
.4
6
E
-0
2
1
.2
7
E
S
I+
H
is
ta
m
in
e
H
is
tid
in
e
m
e
ta
b
o
lis
m
1
.3
4
2
.5
9
E
-0
5
−
8
.1
5
E
S
I+
(R
)-
(+
)-
2
-P
yr
ro
lid
o
n
e
-5
-
c
a
rb
o
xy
lic
a
c
id
D
e
riv
a
tiv
e
o
f
g
lu
ta
m
ic
a
c
id
0
.7
8
4
.9
4
E
-0
2
1
.5
9
E
S
I−
N
-A
c
e
ty
l-
L
-g
lu
ta
m
ic
a
c
id
D
e
riv
a
tiv
e
o
f
g
lu
ta
m
ic
a
c
id
0
.9
1
7
.0
6
E
-0
3
1
.5
3
E
S
I+
L
-T
h
re
o
n
in
e
G
ly
c
in
e
,
se
rin
e
a
n
d
th
re
o
n
in
e
m
e
ta
b
o
lis
m
1
.1
6
1
.1
3
E
-0
3
−
2
.1
6
E
S
I−
S
p
h
in
g
o
si
n
e
S
p
h
in
g
o
lip
id
m
e
ta
b
o
lis
m
1
.1
3
1
.3
5
E
-0
3
−
5
.6
2
E
S
I+
S
p
h
in
g
a
n
in
e
S
p
h
in
g
o
lip
id
m
e
ta
b
o
lis
m
1
.1
2
1
.4
2
E
-0
3
−
5
.1
4
E
S
I+
S
p
h
in
g
o
si
n
e
-1
-p
h
o
sp
h
a
te
S
p
h
in
g
o
lip
id
m
e
ta
b
o
lis
m
0
.9
8
2
.8
9
E
-0
3
1
.4
6
1
.3
6
1
.3
0
E
-0
5
−
1
.8
0
E
S
I+
G
ly
c
e
ro
p
h
o
sp
h
o
c
h
o
lin
e
C
h
o
lin
e
m
e
ta
b
o
lis
m
1
.4
1
3
.4
4
E
-0
8
−
3
.5
7
1
.4
6
4
.4
7
E
-0
7
−
3
.9
6
E
S
I+
P
h
o
sp
h
o
c
h
o
lin
e
C
h
o
lin
e
m
e
ta
b
o
lis
m
1
.3
8
1
.6
2
E
-0
7
−
1
.8
0
E
S
I+
A
c
e
ty
lc
h
o
lin
e
C
h
o
lin
e
m
e
ta
b
o
lis
m
1
.0
6
9
.4
9
E
-0
4
1
.4
4
1
.2
8
9
.8
3
E
-0
5
−
5
.4
9
E
S
I+
c
h
o
le
st
e
ro
ls
u
lfa
te
S
te
ro
id
h
o
rm
o
n
e
b
io
sy
n
th
e
si
s
0
.8
7
1
.0
3
E
-0
2
4
.3
4
E
S
I+
d
e
so
xy
c
o
rt
ic
o
st
e
ro
n
e
a
c
e
ta
te
S
te
ro
id
h
o
rm
o
n
e
b
io
sy
n
th
e
si
s
1
.0
3
3
.4
1
E
-0
3
1
.6
3
E
S
I−
C
o
rt
is
o
l
S
te
ro
id
h
o
rm
o
n
e
b
io
sy
n
th
e
si
s
1
.1
5
9
.5
8
E
-0
4
2
.1
1
E
S
I+
2
5
-h
yd
ro
xy
vi
ta
m
in
D
3
S
te
ro
id
h
o
rm
o
n
e
b
io
sy
n
th
e
si
s
1
.3
3
1
.4
9
E
-0
6
8
.0
0
1
.3
4
2
.4
3
E
-0
5
1
1
.6
6
E
S
I+
G
ly
c
o
c
h
o
lic
A
c
id
B
ile
a
c
id
s
0
.8
5
1
.2
2
E
-0
2
4
.2
4
1
.2
3
2
.4
9
E
-0
4
−
1
.6
1
E
S
I+
G
ly
c
o
d
e
o
xy
c
h
o
la
te
B
ile
a
c
id
s
0
.8
6
1
.8
3
E
-0
2
3
.2
2
E
S
I−
D
e
o
xy
c
h
o
lic
a
c
id
B
ile
a
c
id
s
1
.1
1
1
.2
2
E
-0
3
6
.2
6
1
.1
6
1
.1
8
E
-0
3
3
.1
8
E
S
I−
D
o
d
e
c
a
n
e
d
io
ic
a
c
id
D
ic
a
rb
o
xy
lic
a
c
id
1
.1
9
3
.4
5
E
-0
4
3
.9
7
1
.2
3
4
.2
3
E
-0
4
−
3
.8
7
E
S
I−
Ly
so
P
C
(1
4
:0
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.4
7
2
.3
7
E
-0
7
−
2
.1
1
E
S
I+
Ly
so
P
C
(1
5
:0
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.4
2
1
.6
5
E
-0
6
−
3
.2
6
E
S
I+
Ly
so
P
C
(1
6
:0
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.4
4
3
.9
9
E
-0
9
−
2
.7
7
1
.2
0
4
.2
1
E
-0
4
−
1
.3
4
E
S
I+
Ly
so
P
C
(1
7
:0
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.3
4
1
.0
8
E
-0
6
−
4
.4
9
1
.3
8
7
.4
1
E
-0
6
−
4
.7
4
E
S
I+
Ly
so
P
C
(1
7
:1
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.4
6
3
.6
8
E
-0
7
−
2
.7
6
E
S
I+
Ly
so
P
C
(1
8
:0
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.3
6
3
.8
3
E
-0
7
−
2
.3
2
1
.1
9
5
.7
0
E
-0
4
−
1
.5
0
E
S
I+
Ly
so
P
C
(1
8
:1
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.2
4
2
.5
5
E
-0
5
−
1
.6
9
1
.3
0
5
.9
1
E
-0
5
−
1
.8
3
E
S
I+
Ly
so
P
C
(1
8
:2
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.0
3
1
.5
4
E
-0
3
−
1
.6
5
1
.3
1
5
.4
4
E
-0
5
−
1
.8
7
E
S
I+
Ly
so
P
C
(1
9
:0
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.3
3
1
.8
0
E
-0
5
−
1
.6
9
1
.2
4
3
.6
3
E
-0
4
−
1
.6
9
E
S
I+
Ly
so
P
C
(2
0
:1
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.4
5
2
.2
8
E
-0
9
−
2
.2
8
E
S
I+
Ly
so
P
C
(2
0
:2
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.2
4
2
.8
7
E
-0
5
−
1
.5
6
E
S
I+
Ly
so
P
C
(2
0
:4
)
G
ly
c
e
ro
p
h
o
sp
h
o
lip
id
m
e
ta
b
o
lis
m
1
.2
8
8
.1
2
E
-0
6
−
1
.8
0
1
.4
2
2
.3
0
E
-0
6
−
1
.5
9
E
S
I+
V
IP
,
V
a
ri
a
b
le
Im
p
o
rt
a
n
c
e
in
th
e
P
ro
je
c
ti
o
n
;
F
C
,
fo
ld
c
h
a
n
g
e
;
S
M
,
p
ig
le
ts
in
fe
c
te
d
w
it
h
C
S
F
V
S
h
im
e
n
s
tr
a
in
;
d
p
i,
d
a
y
p
o
s
t
in
fe
c
ti
o
n
.
Frontiers in Microbiology | www.frontiersin.org 8 April 2017 | Volume 8 | Article 731
Gong et al. Serum Metabolomics of CSFV-Infected Piglets
FIGURE 3 | Heat map of differentially expressed metabolites in piglets infected with CSFV. Each row shows ion intensity plots of specific metabolites in the
serum collected from healthy subjects and CSFV challenged piglets (SM). The dendrogram in the left side of the heat map was generated by using MATLAB 7.5. The
leaf nodes of this dendrogram represent individual metabolites and the remaining nodes represent the clusters to which the metabolites belong. The distance between
merged clusters is monotone increasing with the level of the merger. The horizontal distance of each node in the plot is proportional to the value of the intergroup
dissimilarity between its two daughter nodes.
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FIGURE 4 | Schematic representation of altered metabolic pathways in piglets infected with CSFV. Serum metabolomics of CSFV-infected piglets (SM) were
performed by UPLC-MS and many metabolites and associated metabolic pathways were significantly changed with the development of CSF, including
tryptophan/kynurenine metabolism, fatty acid biosynthesis, TCA and urea cycles, amino acids, and nucleotide metabolism. Red: up-regulation; green:
down-regulation.
and hippuric acid were down-regulated, but metabolite
4-aminosalicylic acid produced from phenylalanine degradation
was significantly elevated during infection (Figure 4 and
Table 1), an observation consistent with the increased levels
of phenylalanine. Further, perturbation of phenylalanine
metabolism to tyrosine was observed during CSFV infection, but
the tyrosine derivative, dopamine, was unexpectedly increased.
Equol, the gut bacteria-regulated metabolite from daidzein,
was observed to be elevated at dpi 3 and decreased at dpi
7 following infection (Table 1), a change that may further
reflect the perturbation of the gut microbiota induced by CSFV
infection. Altogether, the above results clearly implicate the
involvement of gut microorganims in the serum metabolite
profiles in CSFV-infected piglets.
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Altered Nucleotide Metabolism and Urea
Cycle in CSFV-Infected Piglets
Nucleotides cytidine and guanine were down-regulated during
CSFV infection as well as AMP, but cytosine and guanosine were
found to be elevated at dpi 3 and subsequently down-regulated at
dpi 7. Although inosine was found to be elevated only in the early
stages of CSFV infection, its derivatives uric acid and allantoin
were significantly up-regulated throughout.
In addition to the alterations in nucleotide metabolism,
nitrogen homeostasis was also perturbed during infection, as
evidenced by the decreased levels of citrulline and ornithine and
the elevation of urea. Further, metabolism of arginine to creatine
and creatinine was elevated. This is an important observation
since urea and creatinine accumulated in the serum are indicators
of kidney failure. Also, the elevated levels of uric acid, allantoin
and the gut bacteria-regulated metabolite p-cresol sulfate reflect
the occurrence of uremia in CSFV-infected piglets.
DISCUSSION
In the present study, we analyzed the serummetabolomic profiles
of CSFV-infected piglets using UPLC/ESI–Q-TOF-MS. PLS-
DA modeling and clustering revealed significant differences in
the global serum metabolite profiles between healthy controls
and animals infected with the highly virulent CSFV Shimen
strain. Metabolites in energy metabolism and aromatic amino
acid metabolism were especially affected following infection.
Further, serum metabolite profiles of CSFV-infected piglets
clearly demonstrate that the perturbation of host metabolites
or metabolic pathways is associated with microbial metabolism,
especially the composition and function of gut microbiota. In
previous proteomics studies regarding CSFV Shimen infection,
only metabolic enzymes involved in glycolysis and TCA cycle,
including glyceraldehyde 3-phosphate dehydrogenase (GAPDH),
phosphoglycerate mutase (PGAM1), and malate dehydrogenase,
were found to be differentially expressed among altered proteins
(Sun et al., 2008, 2010). Therefore, this study provided more
information about alteration of metabolites and associated
pathways in piglets following CSFV infection.
Several pathways involved in energy metabolism were found
to be perturbed during CSFV infection, including the TCA cycle,
fatty acid biosynthesis and β-oxidation, BCAA degradation, and
the metabolism of other amino acids (Figure 5). The serum
levels of citric, succinic, fumaric, and malic acids, which are
TCA cycle intermediates for ATP production, were decreased
during the infection period, indicating that the highly virulent
CSFV Shimen strain can inhibit the energy-producing TCA
cycle. Another energy pathway for acetyl-CoA production, fatty
acid β-oxidation, was also suppressed immediately following
CSFV infection, as evidenced by the substantial accumulation of
long chain saturated and unsaturated fatty acids, carnitine, and
acylcarnitines.
In addition, elevated levels of long chain fatty acids suggest
that CSFV infection promotes fatty acid biosynthesis, which may
in turn facilitate the formation of membranous viral replication
complexes and promote viral propagation. It has been reported
that dengue infection also causes the accumulation of long
chain fatty acids and acylcarinitines in the serum of patients
(Sun et al., 2013). Indeed, several viruses within the family
Flaviviradae can hijack the fatty acid biosynthesis pathway and
impair β-oxidation. Dengue virus (DENV) infection redistributes
fatty acid synthase to viral replication sites through interaction
between non-structural protein 3 (NS3) and fatty acid synthase
in order to promote cellular fatty acid synthesis (Heaton et al.,
2010). In addition, DENV replication can also be enhanced by
Rab18 through targeting fatty acid synthase to sites of viral
replication (Tang et al., 2014). In hepatitis C, hepatitis C virus
FIGURE 5 | Altered energy metabolism in piglets infected with CSFV. During CSF infection (SM), metabolic pathways associated with energy metabolism
including TCA cycle, fatty acid biosynthesis, and β-oxidation, branched amino acids were significantly altered. Red: up-regulation; green: down-regulation.
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(HCV) infection not only upregulates the expression of fatty acid
synthase but also attenuates mitochondrial β-oxidation through
down-regulation of mitochondrial trifunctional protein (MTP)
(Yang et al., 2008; Amako et al., 2015). This situation is similar
to Japanese encephalitis viral infection, which impairs fatty acid
β-oxidation through interaction between viral non-structural
protein 5 (NS5) and hydroxyacyl-CoA dehydrogenase α and β
subunits, two components of MTP involved in long chain fatty
acid β-oxidation (Kao et al., 2015). The underlying mechanisms
of fatty acid biosynthesis and β-oxidation hijacked by CSFV
infection therefore merit further investigation.
BCAAs and their derivative BCFAs are also important sources
of energy production as are other amino acids including
methionine and threonine (Guo et al., 2015; Neis et al.,
2015). Degradation of these produces acetyl-CoA and/or TCA
cycle intermediates for energy production. In general, BCAAs
are broken down by the action of multifunctional branched
chain α-ketoacid dehydrogenase complex (BCKDH), which
converts them into acyl-CoA derivatives and subsequently
into acetyl-CoA or succinyl-CoA that enter the TCA cycle
(Shimomura et al., 2006). A deficiency of BCKDH causes the
accumulation of BCAAs and their toxic by-product BCFAs (L-
α-hydroxyisovaleric acid, α-ketoisovaleric acid, and 3-methyl-
2-oxovaleric acid) in the blood and urine, resulting in a
condition known as maple syrup urine disease (MSUD), which
accumulates damage in mitochondrial DNA and nuclear DNA
and subsequently impairs mitochondrial biogenesis (Aevarsson
et al., 2000; Strand et al., 2014). Symptoms of MSUD, including
anorexia, vomiting, dehydration, seizures, and coma have been
commonly observed in infected piglets following CSFV infection,
indicating the potential involvement of increased levels of
BCAAs and their derivatives in the disease progression. Since
BCAAs are essential amino acids and cannot be synthesized
by host, but bacteria, which carry genes encoding multiple
acetohydroxy acid synthase (AHAS) isozymes, can catalyze the
production of acetolactate (a precursor of valine, leucine, and
co-enzyme A) through decarboxylation of pyruvate and its
condensation either with a second molecule of pyruvate, or with
2-ketobutyrate to produce acetohydroxybutyrate (a precursor of
isoleucine) (Epelbaum et al., 1998), and degradation of BCAAs
can also be performed by bacteria (Massey et al., 1976). Therefore,
it appears that inhibition of BCAA degradation not only leads to
suppression of energy production but also contributes to disease
development in CSFV-infected piglets. However, it remains
undetermined how CSFV infection regulates the expression or
activity of BCKDH in piglet and AHAS in gut bacteria and then
suppresses the degradation of BCAAs.
We found that aromatic amino acid metabolites, including
serotonin, kynurenine, indole-containing metabolites,
phenylalanine, and equol, were significantly perturbed
in infected animals. Serotonin, kynurenine, and indole-
containing metabolites are tryptophan derivatives, alteration
of these metabolites indicates that CSFV infection changed
tryptophan metabolism. Serotonin is a well-documented
neurotransmitter and plays an important role in the brain-gut
microbiome axis, which has been implicated in gastrointestinal
pathologies such as irritable bowel syndrome and Crohn’s
disease (O’Mahony et al., 2015), which can cause depression,
alternative constipation and diarrhea, the common clinical signs
of CSF.
The tryptophan-kynurenine pathway catabolizes tryptophan
to produce NAD. In eukaryotes catabolism of tryptophan
to kynurenine is the rate-limiting step in this pathway.
Intermediates in the kynurenine pathway such as kynurenine
and quinolinic acid are known to induce the apoptosis of
lymphocytes, especially Th1 and NK cells, inhibition of T-cell
proliferation, enhancement of regulatory T-cell proliferation,
and inhibition of the production of type I interferon (IFN-I)
(Fallarino et al., 2002; Boasso et al., 2007; Hoshi et al., 2010,
2012; Song et al., 2011). High activity of indoleamine 2,3-
dioxygenase (IDO) has been reported to be associated with renal
insufficiency in nephropathia epidemica (Puumala hantavirus
infection) (Outinen et al., 2011). It is well-known that leukopenia
and inhibition of IFN-I production are typical features of
CSFV infection, and since marked increases in kynurenine and
quinolinic acid were observed at dpi 3 with a peak at dpi 7,
the CSFV-activated kynurenine pathway may serve as a critical
contributor to the disease progression of CSF. In addition to the
eukaryotic tryptophan-to-quinolinate pathway, the biosynthesis
of quinolinic acid can also be performed by the bacterial
aspartate-to-quinolinate pathway, which was reported to be
involved in the pathogenesis of HIV infection (Lima et al., 2009;
Vujkovic-Cvijin et al., 2013). Thus, studies should be performed
in future to test whether the elevated kynurenine and quinolinate
levels in the sera of CSFV-infected piglets are associated with the
gut microbiota and subsequently cause immunosuppression and
renal failure.
Other indole-containing metabolites were also affected by
CSFV infection, including elevation of indoxylsulfinic acid and
significantly down-regulation of 3-IPA and indoleacetaldehyde.
Indoxylsulfinic acid has been identified as being generated only
by gut microbiota (Wikoff et al., 2009). It is a known uremic
toxin that accumulates in the blood of patients suffering from
chronic kidney disease and arises from hepatic transformation
of the bacterial metabolite indole (Deguchi et al., 2002). The
accumulation of indoxysulfinic acid together with elevated urea,
p-cresol sulfate, uric acid, allantoin, creatine, and creatinine
strongly associate with the occurrence of uremia in CSF
(Deguchi et al., 2002; Meyer and Hostetter, 2012), which can
cause signs and symptoms within multiple systems (Meyer and
Hostetter, 2007), e.g., coma, superficial gastrointestinal ulcers and
pulmonary edema, all of which are commonly observed during
CSF. Thus, altered metabolites associated with uremia may
contribute to the disease development of CSF and the occurrence
of kidney failure. 3-IPA is a powerful antioxidant and metabolite
of indole, the production of which is completely dependent
on the presence of gut microbiota and can be established by
colonization with the bacterium Clostridium sporogenes (Wikoff
et al., 2009). In addition, metabolism of aromatic amino acids
phenylalanine and its derivatives and the flavone metabolite,
equol, which were altered in CSFV-infected piglets, was also
reported to be regulated by bacteria (Parent et al., 2002; Wikoff
et al., 2009; Lu et al., 2012; Meyer and Hostetter, 2012). Taken
together, altered levels of aromatic amino acids and other
Frontiers in Microbiology | www.frontiersin.org 12 April 2017 | Volume 8 | Article 731
Gong et al. Serum Metabolomics of CSFV-Infected Piglets
differential metabolites in the serum of infected piglets may
provide an indication of intestinal dysbiosis induced by CSFV
infection, which will be confirmed in future studies.
In summary, we have analyzed the serum metabolomics
of CSFV-infected piglets and shown that changes in the
levels of certain metabolites can separate infected animals
from healthy ones. Perturbed metabolic pathways include the
tryptophan/kynurenine pathway, fatty acid biosynthesis and β-
oxidation, the TCA, and urea cycles, and nucleotide metabolism.
Impairment of these pathways has revealed that inhibition of
energy production and possibly dysbiosis of the gut microbiota
are critical contributors to the disease development of CSF.
Our studies provide direct evidence that CSFV infection can
cause significant alteration of lipid metabolism and many other
metabolic pathways, similar to that occurs in human infections
caused by DENV and HCV. Thus, metabolomics profiling of
CSFV-infected piglets not only provides new insights into the
disease progression of CSF, but also may serve as a model
for evaluating therapeutics targeting flavivirus infection in
humans.
AUTHOR CONTRIBUTIONS
WG and JJ contributed to design of the study and draft
the manuscript, BZ, SM, LZ, and XX contributed to sample
collection and data analysis, HG, JS, and CT critically revised the
manuscript.
FUNDING
This work was supported by the following grants: National
Natural Science Foundation of China to WG (No. 31572528)
and to CT (No. 31130052), and China Postdoctoral Science
Foundation project to WG (No. 2013M532129). WG and JS were
also partially supported by a National Bio- and Argo-defense
Facility Transition award.
REFERENCES
Aevarsson, A., Chuang, J. L., Wynn, R. M., Turley, S., Chuang, D. T.,
and Hol, W. G. (2000). Crystal structure of human branched-chain
alpha-ketoacid dehydrogenase and the molecular basis of multienzyme
complex deficiency in maple syrup urine disease. Structure 8, 277–291.
doi: 10.1016/S0969-2126(00)00105-2
Amako, Y., Munakata, T., Kohara, M., Siddiqui, A., Peers, C., and Harris,
M. (2015). Hepatitis C virus attenuates mitochondrial lipid β-oxidation by
downregulating mitochondrial trifunctional-protein expression. J. Virol. 89,
4092–4101. doi: 10.1128/JVI.01653-14
Boasso, A., Herbeuval, J. P., Hardy, A. W., Anderson, S. A., Dolan, M. J.,
Fuchs, D., et al. (2007). HIV inhibits CD4+ T-cell proliferation by inducing
indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109,
3351–3359. doi: 10.1182/blood-2006-07-034785
Cui, L., Lee, Y. H., Kumar, Y., Xu, F. G., Lu, K., Ooi, E. E., et al. (2013). Serum
metabolome and lipidome changes in adult patients with primary dengue
infection. PLoS Negl. Trop. Dis. 7:e2373. doi: 10.1371/journal.pntd.0002373
Deguchi, T., Ohtsuki, S., Otagiri,M., Takanago, H., Asaba, H.,Mori, S., et al. (2002).
Major role of organic anion transporter 3 in the transport of indoxyl sulfate in
the kidney. Kidney Int. 61, 1760–1768. doi: 10.1046/j.1523-1755.2002.00318.x
Epelbaum, S., Larossa, R. A., Vandyk, T. K., Elkayam, T., Chipman, D. M.,
and Barak, Z. (1998). Branched-chain amino acid biosynthesis in Salmonella
typhimurium: a quantitative analysis. J. Bacteriol. 180, 4056–4067.
Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A.,
et al. (2002). T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9,
1069–1077. doi: 10.1038/sj.cdd.4401073
Floegel-Niesmann, G., Bunzenthal, C., Fischer, S., and Moennig, V. (2003).
Virulence of recent and former classical swine fever virus isolates evaluated
by their clinical and pathological signs. J. Vet. Med. 50, 214–220.
doi: 10.1046/j.1439-0450.2003.00663.x
Guo, L. N., Milburn, M. V., Ryals, J. A., Lonergan, S. C., Mitchell, M. W., Wuff, J.
E., et al. (2015). Plasma metabolomics profiles enhance precision medicine for
volunteers of normal health. Proc. Natl. Acad. Sci. U.S.A. 112, E4901–E4910.
doi: 10.1073/pnas.1508425112
Heaton, N. S., Perera, R., Berger, K. L., Khadka, S., LaCount, D. J., Kuhn, R. J., et al.
(2010). Dengue virus nonstructural protein 3 redistributes fatty acid synthase
to sites of viral replication and increase cellular fatty acid synthesis. Proc. Natl.
Acad. Sci. U.S.A. 107, 17345–17350. doi: 10.1073/pnas.1010811107
Hoshi, M., Matsumoto, K., Ito, H., Ohtaki, H., Arioka, Y., Osawa, Y.,
et al. (2012). L-Tryptophan-kynurenine pathway metabolites regulate type
I IFNs of acute viral myocarditis in mice. J. Immunol. 188, 3980–3987.
doi: 10.4049/jimmunol.1100997
Hoshi, M., Saito, K., Hara, A., Taguchi, A., Ohtaki, H., Tanaka, R., et al. (2010). The
absence of IDO upregulates type I IFN production, resulting in suppression of
viral replication in the retrovirus-infected mouse. J. Immunol. 185, 3305–3312.
doi: 10.4049/jimmunol.0901150
Ji, W., Guo, Z., Ding, N. Z., and He, C. Q. (2015). Studying classical
swine fever virus: making the best of a bad virus. Virus Res. 197, 35–47.
doi: 10.1016/j.virusres.2014.12.006
Kao, Y. T., Chang, B. L., Liang, J. J., Tsai, H. J., Lee, Y. L., Lin, R. J., et al.
(2015). Japanese encephalitis virus nonstructural protein NS5 interacts with
mitochondrial trifunctional protein and impairs fatty acid β-oxidation. PLoS
Pathog. 11:e1004750. doi: 10.1371/journal.ppat.1004750
Lima, W. C., Varani, A. M., and Menck, C. F. M. (2009). NAD biosynthesis
evolution in bacteria: lateral gene transfer of kynurenine pathway in
Xanthomonadales and Flavobacteriales. Mol. Biol. Evol. 26, 399–406.
doi: 10.1093/molbev/msn261
Lu, K., Knutson, C. G., Wishnok, J. S., Fox, J. G., and Tannenbaum, S. R.
(2012). Serum metabolomics in a Helicobacter hepaticus mouse model of
inflammatory bowel disease reveal important changes in the microbiome,
serum peptides, and intermediary metabolism. J. Proteome Res. 11, 4916–4926.
doi: 10.1021/pr300429x
Massey, L. K., Sokatch, J. R., and Conrad, R. S. (1976). Branched-chain amino acid
catabolism in bacteria. Bacteriol. Rev. 40, 42–54.
Meyer, T.W., andHostetter, T. H. (2007). Uremia.N. Engl. J. Med. 357, 1316–1325.
doi: 10.1056/NEJMra071313
Meyer, T. W., and Hostetter, T. H. (2012). Uremic solutes from colon microbes.
Kidney Int. 81, 949–954. doi: 10.1038/ki.2011.504
Moennig, V., Floegel-Niesmann, G., and Greiser-Wilke, I. (2003). Clinical signs
and epidemiology of classical swine fever: a review of new knowledge. Vet. J.
165, 11–20. doi: 10.1016/S1090-0233(02)00112-0
Neis, E. P. J. G., Dejong, C. H. C., and Rensen, R. S. (2015). The role of
microbial amino acid metabolism in host metabolism. Nutrients 7, 2930–2946.
doi: 10.3390/nu7042930
Ni, Y., Xie, G. X., and Jia, W. (2014). Metabonomics of human colorectal cancer:
new approaches for early diagnosis and biomarker discovery. J. Proteome Res.
13, 3857–3870. doi: 10.1021/pr500443c
O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., and Cryan, J. F. (2015).
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav.
Brain Res. 277, 32–48. doi: 10.1016/j.bbr.2014.07.027
Outinen, T. K., Mäkelä, S. M., Ala-Houhala, I. O., Huhtala, H. S. A., Hurme,
M., Libraty, D. H., et al. (2011). High activity of indoleamine 2,3-dioxygenase
is associated with renal insufficiency in Puumala hantavirus induced by
nephropathia epidemica. J. Med. Virol. 83, 731–737. doi: 10.1002/jmv.
22018
Frontiers in Microbiology | www.frontiersin.org 13 April 2017 | Volume 8 | Article 731
Gong et al. Serum Metabolomics of CSFV-Infected Piglets
Parent, M. A., Bellaire, B. H., Murphy, E. A., Roop, I. I., R. M., Elzer, P. H., and
Baldwin, C. L. (2002). Brucella abortus siderophore 2,3-dihydroxybenzoic acid
(DHBA) facilitates intracellular survival of the bacteria. Microb. Pathog. 32,
238–248. doi: 10.1006/mpat.2002.0500
Shi, Z. X., Sun, J. F., Guo, H. C., and Tu, C. C. (2009). Genomic expression
profiling of peripheral blood leukocytes of piglets infected with highly virulent
classical swine fever virus strain Shimen. J. Gen. Virol. 90, 1670–1680.
doi: 10.1099/vir.0.009415-0
Shimomura, Y., Honda, T., Shiraki, M., Murakami, T., Sato, J., Kobayashi, H., et al.
(2006). Branched-chain amino acid catabolism in exercise and liver disease. J.
Nutr. 136, 250S–253S.
Song, H., Park, H., Kim, Y. S., Kim, K. D., Lee, H. K., Cho, D. H.,
et al. (2011). L-Kynurenine-induced apoptosis in human NK cells is
mediated with reactive oxygen species. Int. Immunopharmacol. 11, 932–938.
doi: 10.1016/j.intimp.2011.02.005
Strand, J. M., Skinnes, R., Scheﬄer, K., Rootvelt, T., Woldseth, B., Bjørås,
M., et al. (2014). Genome instability in maple syrup urine disease
correlates with impaired mitochondrial biogenesis.Metabolism 63, 1063–1070.
doi: 10.1016/j.metabol.2014.05.003
Sun, H., Zhang, A. H., Yan, G. L., Piao, C. Y., Li, W. Y., Sun, C., et al. (2013).
Metabolomic analysis of key regulatorymetabolites in hepatitis C virus-infected
tree shrews. Mol. Cell. Proteomics 12, 710–719. doi: 10.1074/mcp.M112.
019141
Sun, J. F., Jiang, Y., Shi, Z. X., Yan, Y. J., Guo, H. C., He, F. C.,
et al. (2008). Proteomic alteration of PK-15 cells after infection by
classical swine fever virus. J. Proteome Res. 7, 5263–5269. doi: 10.1021/pr8
00546m
Sun, J. F., Shi, Z. X., Guo, H. C., and Tu, C. C. (2010). Changes in the
porcine peripheral blood mononuclear cell proteome induced by infection
with highly virulent classical swine fever virus. J. Gen. Virol. 91, 2254–2262.
doi: 10.1099/vir.0.022020-0
Tang, W. C., Lin, R. J., Liao, C. L., and Lin, Y. L. (2014). Rab18 facilitates dengue
virus infection by targeting fatty acid synthase to sites of viral replication. J.
Virol. 88, 6793–6804. doi: 10.1128/JVI.00045-14
Vujkovic-Cvijin, I., Dunham, R. M., Iwai, S., Maher, M. C., Albright, R. G.,
Broadhurst, M. J., et al. (2013). Dysbiosis of the gut microbiota is associated
with HIV disease progression and tryptophan catabolism. Sci. Transl. Med. 5,
193ra91. doi: 10.1126/scitranslmed.3006438
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C.,
et al. (2009). Metabolomics analysis reveals large effects of gut microflora on
mammalian blood metabolites. Proc. Natl. Acad. Sci. U.S.A. 106, 3698–3703.
doi: 10.1073/pnas.0812874106
Yang, W., Hood, B. L., Chadwick, S. L., Liu, S. F., Watkins, S. C., Luo, G. X., et al.
(2008). Fatty acid synthase is up-regulated during hepatitis C virus infection
and regulates hepatitis C virus entry and production. J. Proteome Res. 48,
1396–1403. doi: 10.1002/hep.22508
Zhou, L. N., Ding, L. L., Yin, P. Y., Lu, X., Wang, X. M., Niu, J. Q., et al.
(2012). Serum metabolic profiling study of hepatocellular carcinoma infected
with hepatitis B or hepatitis C virus by using liquid chromatography-mass
spectrometry. J. Proteome Res. 11, 5433–5442. doi: 10.1021/pr300683a
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Gong, Jia, Zhang, Mi, Zhang, Xie, Guo, Shi and Tu. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Microbiology | www.frontiersin.org 14 April 2017 | Volume 8 | Article 731
